APA (7th ed.) Citation

AlHammadi, A. A., Alzaabi, A. H., Choker, H. B., Ibrahim, A. A., Ishaq, A. B., Mahboub, A. E., . . . Al-Ramadi, B. K. A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment for SARS-СoV-2 infection in the United Arab Emirates. Elsevier.

Chicago Style (17th ed.) Citation

AlHammadi, Ahmed A.K., et al. A Phase II/III, Randomized, Double-blind, Placebo-controlled Trial to Evaluate Immunogenicity and Safety of the Gam-COVID-Vac Combined Vector Vaccine in the Prophylactic Treatment for SARS-СoV-2 Infection in the United Arab Emirates. Elsevier.

MLA (9th ed.) Citation

AlHammadi, Ahmed A.K., et al. A Phase II/III, Randomized, Double-blind, Placebo-controlled Trial to Evaluate Immunogenicity and Safety of the Gam-COVID-Vac Combined Vector Vaccine in the Prophylactic Treatment for SARS-СoV-2 Infection in the United Arab Emirates. Elsevier.